Bayesian Hierarchical Clustering for Studying Cancer Gene Expression Data with Unknown Statistics by Sirinukunwattana, Korsuk et al.
Bayesian Hierarchical Clustering for Studying Cancer
Gene Expression Data with Unknown Statistics
Korsuk Sirinukunwattana1, Richard S. Savage2, Muhammad F. Bari3,4, David R. J. Snead3,4,
Nasir M. Rajpoot1,5*
1Department of Computer Science, The University of Warwick, Coventry, United Kingdom, 2Warwick Systems Biology Centre, The University of Warwick, Coventry,
United Kingdom, 3Department of Pathology, University Hospitals Coventry & Warwickshire, Coventry, United Kingdom, 4Divisions of Reproduction and Metabolic &
Vascular Health, Warwick Medical School, Coventry, United Kingdom, 5Department of Computer Science and Engineering, Qatar University, Doha, Qatar
Abstract
Clustering analysis is an important tool in studying gene expression data. The Bayesian hierarchical clustering (BHC)
algorithm can automatically infer the number of clusters and uses Bayesian model selection to improve clustering
quality. In this paper, we present an extension of the BHC algorithm. Our Gaussian BHC (GBHC) algorithm represents
data as a mixture of Gaussian distributions. It uses normal-gamma distribution as a conjugate prior on the mean and
precision of each of the Gaussian components. We tested GBHC over 11 cancer and 3 synthetic datasets. The results on
cancer datasets show that in sample clustering, GBHC on average produces a clustering partition that is more
concordant with the ground truth than those obtained from other commonly used algorithms. Furthermore, GBHC
frequently infers the number of clusters that is often close to the ground truth. In gene clustering, GBHC also produces
a clustering partition that is more biologically plausible than several other state-of-the-art methods. This suggests GBHC
as an alternative tool for studying gene expression data. The implementation of GBHC is available at https://sites.
google.com/site/gaussianbhc/
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Introduction
Clustering analysis is an important tool in studying genomic
data such as gene expression profiles and can be used to infer
biological function and regulation of genes. Eisen et al. [1] found
that in yeast S. cerevisiae, genes that are clustered together often
share similar biological function or are co-regulated, leading to
the recognition that genes in the same cluster can be
functionally related or regulated by a common set of transcrip-
tion factors. It has been shown in the literature that biological
function of a cluster can be inferred from ontology annotation of
its genes [2], and biological function of an uncharacterized gene
can also be inferred from the knowledge of genes in its cluster
[3,4]. Moreover, in modern medical research, clustering analysis
has been used to identify disease subtypes based on genetic
variation [5,6], and to identify a gene expression signature that
can be used as a prognostic marker for known disease subtypes
[7–9]. This aids stratification of patients for personalized
medicine.
Numerous commonly used clustering algorithms have a
significant limitation in that they rely on ad hoc methods to
identify the number of clusters within the data. In hierarchical
clustering algorithms [10–12], for example, identifying the
number of clusters mainly depends on visual identification,
whereas the number of clusters is required as an input to other
algorithms such as k-means [13] and self-organizing map [14].
Furthermore, many clustering algorithms require the choice of a
distance metric to indicate the strength of similarity/dissimilar-
ity between data points or clusters. However, there is little
systematic guidance about how to choose a metric for data such
as gene expression measurements that reflects reasonably well
the relationship between data. Often, it is difficult to define the
relationship, especially in high-dimensional space. Two com-
mon choices of metrics in gene clustering analysis literature are
Euclidean distance and Pearson correlation coefficient [15].
However, Euclidean distance is sensitive to scaling and
differences in average. Pearson correlation coefficient can only
capture linear relationship between data, and it is not robust to
outliers and non-Gaussian distribution [16]. Model-based
clustering algorithms can address both of these problems. In
model-based algorithms, data are represented by a mixture
model [17,18] of parameterized distributions, in which each
component represents a different cluster. The problems of how
to identify the number of clusters and the distance metric can
therefore be cast as a model selection problem - how to choose a
statistical model that best describes the data.
Bayesian hierarchical clustering (BHC) [19,20] is a model-
based clustering algorithm based on the Dirichlet process
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mixture model (DPM) [18,21,22]. It has strong advantages over
other model-based approaches. First, it produces a hierarchical
clustering structure which is more informative than a flat one.
Second, it uses Bayesian model selection to determine the
hierarchical structure, rather than an ad hoc distance metric,
thereby increasing the quality of resulting clusters. Multinomial
BHC (MBHC) [23] represents the data in each mixture
component as a product of multinomial likelihoods, subject to
a Dirichlet prior, and has been shown to produce higher
dendrogram purity and more biologically meaningful clusters
than other commonly used algorithms for the Arabidopsis
thaliana microarray dataset [23]. However, by using multino-
mial likelihoods, the algorithm requires a categorical approx-
imation of a continuous variable. This may not, therefore,
fully capture the underlying structure of continuous gene
expression data. Gaussian likelihoods are an obvious alterna-
tive here, as they do not require data approximation and have
been used for describing gene expression data in many
clustering analyses. Previous work on expression datasets of
ovary and yeast cell cycle show that model-based clustering
algorithms that use finite Gaussian mixture model produce
comparable quality clusters to a leading heuristic clustering
algorithm, even if the data do not totally satisfy Gaussian
mixture assumption [24]. In a comparative study of clustering
algorithms for cancer gene expression data, given the actual
number of clusters, finite Gaussian model approach is the
leader in assigning data to the correct cluster [25]. Rasmussen
et al. [26] propose a model-based clustering algorithm with
infinite Gaussian mixture model to study Rosetta compendium
of expression profiles of S. cerevisiaie, and find that clustering
results not only confirm previously published clustering
analyses but also reveal finer clustering level that are novel
and biologically consistent.
In this paper, we propose an extension of the BHC
algorithm for gene expression data which we term as the
Gaussian BHC (GBHC). GBHC offers several advantages over
other clustering algorithms: first, it assumes an infinite
Gaussian mixture model for gene expression data, which has
been shown to be biologically plausible in literature [24–26];
second, it employs the mixture model in a Bayesian
framework to perform a model-based hierarchical clustering
of gene expression data revealing hierarchical structure
present in the data; third, it infers the number of clusters
automatically from the data; and fourth, it uses the Gaussian
mixture assumption to describe the data and uses a normal-
gamma distribution as a conjugate prior on unknown means
and precisions of the Gaussian likelihoods. We introduce two
variants of GBHC: one with hyperparameter optimization over
the whole tree (GBHC-TREE), and another with hyperpara-
meter optimization at every merger (GBHC-NODE). Further,
we derive a tractable formulation for speeding up the
hyperparameter optimization in case of GBHC-NODE, result-
ing in a speedup factor of up to 11 over GBHC-TREE. We
compare these two algorithms with a range of other clustering
methods, performing a study over 3 synthetic datasets and 11
cancer gene expression datasets. The results show that although
the data are not very well-represented by a mixture of Gaussian
distributions, both variants still improve the clustering quality if
the data are normalized and do not have strong correlation
between variables. On average, both flavors of our GBHC
algorithm produce clustering results which compare favorably to
the existing approaches.
Materials and Methods
Notations
Bayesian Hierarchical Clustering Algorithm
BHC [19] assumes that data are generated from a mixture
model, in which each cluster within the data corresponds to a
different distribution component of the model. Suppose that data
points x(i) in a cluster Dk are independently and identically
generated from a probabilistic model P x hjð Þ with unknown
parameters h, and h are governed by a prior P(hDj) with
hyperparameters j. Thus, the marginal likelihood of Dk can be
expressed by
P Dk jjð Þ~
ð
P
x ið Þ[Dk
P x ið Þ hj
 " #
P h jjð Þdh: ð1Þ
The algorithm initially places each data point into its own trivial
cluster and iteratively merges the two most similar clusters, until all
the data points are put into a single cluster. This merger process
can be represented by a dendrogram (Figure 1A).
The notion of similarity between clusters is related to the
probability that they should be merged. This is defined based on
Bayesian hypothesis testing as follows. To merge clusters Di and
Dj into Dk (Figure 1B), BHC considers the null hypothesis H0: Di
and Dj belong to Dk and the alternative hypothesis H1: Dk
consists of two or more clusters. The probability that Di and Dj
should be merged is calculated via the Bayes’ rule:
rk~
pkP(Dk DHk0)
P(Dk DTk) , ð2Þ
where a marginal likelihood P(Dk DTk) is defined recursively by
h unknown parameters of a probabilistic model component in a
mixture model
j hyperparameters of a prior on h
i,j,k indices
x
(i)
j
a data value of the jth variable from the ith observation
d total number of data variables
x(i) a data point x(i)~(x(i)1 ,:::,x
(i)
d )
Di,Dj ,Dk the ith, jth, kth cluster of data points, respectively
Ti ,Tj ,Tk a merger that makes Di,Dj ,Dk , respectively
nk number of data points in Dk
a concentration parameter of the Dirichlet process mixture model
rk merger probability
l0,b0,k0 hyperparameters of the marginal likelihood for a Gaussian
distribution with a normal-gamma prior
P(:) probability
C(:) gamma function
y(:) digamma function, defined by y(x)~ d
dx
lnC(x)
N (:) probability density function of a Gaussian distribution
NG(:) probability density function of a normal-gamma distribution
Ga(:) probability density function of a gamma distribution
doi:10.1371/journal.pone.0075748.t006
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P(Dk DTk)~pkP(Dk DHk0)z(1{pk)P(Di DTi)P(Dj DTj), ð3Þ
P(Dk DHk0) is a marginal likelihood of Dk given in Equation (1), and
pk is a prior that Di and Dj should be merged and is defined
recursively by
pk~
aC(nk)
rk
, ð4Þ
rk~aC(nk)zrirj , ð5Þ
where we set pi~1 and ri~a for every initial cluster i. We note
that the definition of pk defined here makes Equation (3) an
approximation of a marginal likelihood of DPM. Moreover, the
value of concentration parameter a is connected to the expected
number of clusters that BHC infers. An increase in a implies an
increase in the expected number of clusters.
At rk§0:5, Di and Dj are more likely to belong to the same
cluster than at rkv0:5. Consequently, we obtain the final number
of clusters and partition when all the remaining pairs of merger
have rkv0:5 (Figure 1C).
The Marginal Likelihood for Gaussian Distribution with
Unknown Mean and Precision
Consider a dataset in which each observation x(i) consists of
d variables, i.e. x(i)~(x
(i)
1 ,:::,x
(i)
d ). We assume that
A 1 the dataset is normalized, i.e. it has mean zero and a
unit variance;
A 2 for each observation x(i), its variables fx(i)j gdj~1 are
independent and generated from different Gaussian distri-
butions;
A 3 the realizations of each variable j, fx(i)j gnki~1 in cluster Dk
are independent and identically distributed and drawn from
Gaussian distribution with unknown mean mj and precision
s{2j , and the prior on (mj ,s
{2
j ) is a normal-gamma
distribution with hyperparameter m0,s0,b0,k0.
The probability density function of a Gaussian distribution is
defined as
N (xDm,s{2)~
ffiffiffiffiffiffiffiffi
s{2
2p
r
exp {
s{2
2
x{mð Þ2
 
, ð6Þ
and the probability density function of a normal-gamma
distribution is defined as
NG(m,s{2jm0,l0,b0,k0)~
b
l0
0
C(l0)
k0
2p
 1
2
s{2(l0{
1
2
)
exp {
s{2
2
(k0(m{m0)
2z2b0)
 
:
ð7Þ
From the above assumptions, the marginal likelihood of Dk can
be expressed as
P(Dkjl0,b0,k0)
~Pdj~1
ð
P
nk
i~1N (x(i)j jmj ,s{2j )
h i
NG(mj ,s
{2
j jl0,b0,k0)d(mj ,s{2j )
~Pdj~1
C(lnk )
C(l0)
b
l0
0
b
lnk
nk ,j
k0
knk
 !1
2
(2p){
nk
2
2
4
3
5,
ð8Þ
where
l0,b0,k0w0, ð9Þ
and
knk~k0znk, ð10Þ
Figure 1. Bayesian hierarchical clustering. A) A dendrogram represents the merger process of BHC. Each vertical line represents a cluster. A
horizontal line connecting between any two vertical lines represents the merger of clusters, where its height is related to the dissimilarity measure
between the merged clusters. B) A schematic shows datasets Di and Dj merged into Dk , where Ti ,Tj , and Tk are the associated mergers that make
Di ,Dj , and Dk , respectively. C) BHC prunes the dendrogram at rk~0:5, resulting in the final partition.
doi:10.1371/journal.pone.0075748.g001
Model-Based Clustering for Studying Cancer Data
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e75748
lnk~l0z
nk
2
, ð11Þ
xj~
1
nk
Xnk
i~1
x
(i)
j , ð12Þ
bnk ,j~b0z
1
2
Xnk
i~1
(x
(i)
j {xj)
2z
k0nk(xj)
2
knk
" #
: ð13Þ
In deriving (8), the hyperparameter m0 which indicates the mean of
parameter mj is set to 0 to reflect Assumption A1. Equation (8) is all
that is required for P(DkDHk0) in GBHC.
Hyperparameter Optimization
GBHC infers the values of hyperparameters l0,b0,k0 by using
the information from P(Dk DTk) which tells us how well the
clustering hierarchy fits the data. This inference can be done via
two optimization schemes as follows.
(i) Optimization globally over the whole tree (TREE).
GBHC-TREE finds only one set of optimal hyperparameters
(l0,b

0,k

0) that fits the whole data, and is given by
(l0,b

0,k

0)~ argmax
l0w0,b0w0,k0w0
lnP(Dklast DTklast ), ð14Þ
where P(Dklast DTklast ) is the marginal likelihood (3) of the
final merger in BHC. To learn the optimal hyperparameters
in this case is costly since the gradients of P(Dklast DTklast ) with
respect to hyperparameters are analytically intractable, unless
the structure of the clustering hierarchy is fixed. (See [19] for
more details on optimization of P(Dklast DTklast ) in the case
that the clustering hierarchy is fixed.)
(ii) Optimization at every merger (NODE). GBHC-
NODE finds optimal hyperparameters l0, b

0,k

0 for each
merger Tk in BHC by performing
(l0,b

0,k

0)~ argmax
l0w0,b0w0,k0w0
lnP(l0,b0,k0D k), ð15Þ
where
lnP(l0,b0,k0D k)~ln½P(DkDl0,b0,k0)P(l0)P(b0)P(k0),ð16Þ
and we assume that
l0*Ga(al,bl), ð17Þ
b0*Ga(ab,bb), ð18Þ
k0*Ga(ak,bk): ð19Þ
The probability density function of a Gamma distribution is
defined by
Ga(xDa,b)~
ba
C(a)
xa{1e{xb, aw0,bw0: ð20Þ
Thus the log-likelihood function in (16) can be written as,
lnP(l0,b0,k0jDk)
~d lnC(lnk ){lnC(l0)zl0 ln(b0)z
1
2
ln(k0){
1
2
ln(knk )
 
{lnk
Xd
j~1
ln(bnk ,j)z(al{1)ln(l0){bll0z(ab{1)ln(b0){bbb0
z(ak{1)ln(k0){bkk0zconstant,
ð21Þ
and its gradients with respect to hyperparameters are
L
Ll0
lnP(l0,b0,k0jDk)~
d y(lnk ){y(l0)zln(b0)
h i
{
Xd
j~1
ln(bnk ,j)z
(al{1)
l0
{bl,
ð22Þ
L
Lb0
lnP(l0,b0,k0D k)~
l0d
b0
{lnk
Xd
j~1
1
bnk ,j
z
(ab{1)
b0
{bb, ð23Þ
L
Lk0
lnP(l0,b0,k0jDk)~
nkd
2k0knk
{
lnk
2
nk
knk
 !2Xd
j~1
(xj)
2
bnk ,j
z
(ak{1)
k0
{bk:
ð24Þ
See Section S1 in Material S1 for derivations of Equations (22)–
(24). We use weakly informative priors over hyperparameters in
Equations (17)–(19), assuming that the data are normalized,
al~4,bl~0:1,ab~1:5,bb~0:1,ak~2,bk~1: ð25Þ
We note that Equation (15) is related to the optimization of
P(DkDTk), in which approximation P(DkDTk)&pkP(Dk DHk0)~
pkP(DkDl0,b0,k0) and the maximization of its posterior distribu-
tion is considered. We can see that GBHC-NODE finds the
optimal structure of the clustering hierarchy in a single run by
searching for the best merger at each level while the hierarchy is
constructed. So, it is more time-efficient than GBHC-TREE.
The possible limitation of both optimization schemes is that
the optimization objective functions (14),(15) can be non-
convex. This will result in GBHC-TREE and GBHC-NODE
only finding hyperparameters that are locally optimal. Never-
theless, in our experiments with clustering synthetic data and
gene expression data, both schemes have produced promising
results.
Other Clustering Algorithms
We compare GBHC-TREE and GBHC-NODE to other
clustering algorithms in Table 1. The algorithms and their
Model-Based Clustering for Studying Cancer Data
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similarity/dissimilarity measure will be referred to by the
abbreviations given in the table. For instance, APE stands for
affinity propagation using negative Euclidean distance. Further-
more, we employ L-methods [27] to infer the number of clusters in
AC,AE,CC,CE,KC, and KE, which are the algorithms that
require pre-specified number of clusters.
In this work, we implement GBHC-TREE, GBHC-NODE and
MBHC in MATLAB. We use AP which is publicly available at the
authors’ webpage (http://www.psi.toronto.edu/index.php?q =
affinity\%20propagation). All the remaining algorithms could be
found as MATLAB’s built-in functions.
The Datasets
Synthetic Datasets. GBHC-TREE and GBHC-NODE
should perform very well if the Assumptions A1–A3 are satisfied.
However, real expression data are expected to be not fully satisfied
Gaussian mixture assumption, and the correlation between data
variables is possible. It is very important to evaluate the
performance of GBHC-TREE and GBHC-NODE in comparison
to the other clustering algorithms when some of the assumptions
are violated. Here, we use synthetic datasets to study GBHC-
TREE and GBHC-NODE in three different scenarios as follows
(see Section S2 in Material S1 for more details on how the data are
generated).
Synthetic Dataset1: Mixture of Gaussian Distributions
and Independent Data Variables. 1000 observations of 10-
dimensional random vector are drawn from a mixture of 7
multivariate Gaussian distributions, where each multivariate
Gaussian distribution has diagonal covariance matrix. Then the
data are normalized.
Synthetic Dataset2: Mixture of Gaussian Distributions
and Correlated Data Variables. Similar to the first scenario,
1000 observations of 10-dimensional random vector are drawn
from a mixture of 7 multivariate Gaussian distributions, but the
covariance matrix of each multivariate Gaussian distribution has
non-diagonal entries which are non-zero. Then the data are
normalized.
Synthetic Dataset3: Mixture of Several Distributions. We
generate 1000 observations of 10-dimensional random vector from
a mixture of 7 different multivariate distributions. For the first 6
multivariate components of a mixture, namely Gaussian, gamma,
uniform, student’s t, Weibull, and chi-squared distributions, random
variables in different dimensions are independent. For the last
multivariate component of a mixture which is a Gaussian
distribution, there is correlation between random variables in
different dimensions. This dataset is normalized prior to the
use.
Gene Expression Datasets. The performance of all the
aforementioned clustering algorithms is assessed through 11
cancer datasets, as described in Table 2. Blood1, Blood2, Bone
Marrow, Brain1, Brain2, Colon, Multi-tissue1, Multi-tissue2,
Prostate1 are downloaded from http://algorithmics.molgen.mpg.
de/Static/Supplements/CompCancer/datasets.htm. These data-
sets are already filtered according to the protocol described in [25].
We transform every dataset by log2 and normalize it before using.
Prostate2 is downloaded from Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) (GDS1439). The dataset is
transformed by log2 and then filtered by the Wilcoxon rank-sum
test at significance level 0.001. The test is carried out between a
group of benign and a group of primary and metastatic. The
dataset is normalized before using.
Lung is available at Gene Expression Omnibus (GSE44447).
The microarray experiment of this data was conducted on Agilent
SurePrint G3 Human Gene Expression 8660 K microarrays
(AGilent Technologies, Wokingham, UK), using lung tissues
that were ethically approved under the Multicentre Research
Ethics Committee (MREC) approval. The experiment was
designed to compare the gene expression profiles of two types of
closely related high grade neuroendocrine carcinomas, small
cacinoma and large cell neuroendocrine carcinoma, which are
difficult to classify correctly even for pulmonary pathologists.
The raw expression data was processed using R Bioconductor
package limma (http://www.bioconductor.org/packages/2.10/
bioc/html/limma.html), loess and quantiled normalized and
corrected for batch effect using ComBat (http://www.bu.edu/
jlab/wp-assets/ComBat/Abstract.html). We filter this dataset
using Wilcoxon rank-sum test for testing the difference between
normal and cancer groups at significance level 0.001, and
normalize it prior to clustering.
Clustering Performance Indices
We use two metrics to evaluate the clustering performance: (i)
adjusted Rand index (ARI) [28] and, (ii) biological homogeneity
index (BHI) [29]. In the clustering of synthetic data, since the true
partition of data classes is known, ARI is used as a measure of
agreement between clustering partition and the true partition. ARI
scores a pair of partitions between 0 and 1, and a higher ARI score
indicates higher agreement. We also use ARI in sample clustering
experiment of gene expression data.
In gene clustering of gene expression data, we are interested in
how biologically meaningful the clustering results are. BHI is used
to measure the biological plausibility of gene clustering results
generated by an algorithm. It scores a partition between 0 and 1,
where a higher score will be assigned to the more biological
homogeneous partition based on a reference set of functional
classes. In this case, we use Gene Ontology (GO) annotation in
Bioconductor package (Section S3, Table S1 in Material S1), while
the BHI is calculated using the R package clValid [30].
Results and Discussion
Synthetic Datasets
ARI scores of clustering algorithms are shown in Table 3, and
the numbers of clusters inferred by the algorithms are given in
Section S5, Table S2 in Material S1. Details of the experimental
setting can also be found in Section S4 in Material S1. For visual
inspection of clustering results, we employ a dimension reduction
approach called t-Distributed Stochastic Neighbor Embedding (t-
SNE) [31] algorithm to reduce the dimension of the original
synthetic data into 2-dimensional Euclidean space. t-SNE maps
data by preserving the local structure; thus data which are in the
same cluster will be placed close by each other in the lower-
dimensional space. The visualizations of clustering results are
shown in Figures 2, 3, 4.
Synthetic Dataset1: Mixture of Gaussian Distributions
and Independent Data Variables. When Assumptions A1–
A3 are satisfied, GBHC-TREE and GBHC-NODE outperform
the others by correctly infer the membership of data points as
well as the number of clusters. On the other hand, there are
some minor to high degradation in clustering results from the
other algorithms.
Synthetic Dataset2: Mixture of Gaussian Distributions
and Correlated Data Variables. In the case where Assump-
tion A2 is violated, the performances of GBHC-TREE and
GBHC-NODE are highly effected by the correlation between data
variables. From Figure 3, we can see that GBHC-TREE and
GBHC-NODE infer many sub-clusters of the actual one. The
reason is that a bigger cluster of correlated data provides a
Model-Based Clustering for Studying Cancer Data
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stronger evidence that the data are not generated from the model
underlying GBHC-TREE and GBHC-NODE. Thus, the mar-
ginal likelihood (8) gets smaller as the cluster gets bigger, and
consequently, GBHC-TREE and GBHC-NODE are in favor of
not merging smaller clusters into a bigger one according to Bayes’
rule (2). In our experiment, we found that the degradation depends
on both the number of correlated pairs of variables and the degree
of correlation. The increase in either factor results in the increase
in the number of inferred sub-clusters (see Section S5, Tables
S3,S4 in Material S1 for details).
Synthetic Dataset3: Mixture of Several
Distributions. GBHC-TREE and GBHC-NODE are able to
recognize all the clusters generated from non-Gaussian distri-
butions even if the distributions are highly deviated from the
Gaussian distribution, given that Assumptions A1, A2 are
satisfied.
It is apparent that the strong correlation between data variables
is the main factor that limits the performance of GBHC-TREE
and GBHC-NODE. One could try to transform the data to reduce
the correlation between variables before clustering, but one has to
bear in mind that the transformation might destroy the meaning of
original data variables. Despite the degradation in clustering
results, GBHC-TREE and GBHC-NODE still outperforms all the
other methods on a whole.
Gene Expression Datasets
We compare sample clustering and gene clustering perfor-
mances of GBHC-TREE and GBHC-NODE to those of other
algorithms. Note that, in gene clustering, we treat probes as
observations and the expression levels across different samples as
variables. In sample clustering, on the other way round, samples
are treated as observations and the expression levels across
different probes are treated as variables.
In sample clustering, Table 4 shows that GBHC-NODE and
GBHC-TREE give the highest ARI in 4 datasets (Blood2, Multi-
tissue2, Prostate1, Prostate2) and 2 datasets (Bone Marrow,
Prostate2), respectively. The other algorithms give the highest
ARI in at most 2 datasets. The first three algorithms with the
highest mean ARI are GBHC-NODE, GBHC-TREE, and CC.
However, there are no significant differences between them (p-
Table 1. Clustering algorithm.
Algorithm Similarity/Dissimilarity Metric Ability to Infer # Clusters Reference
AP: affinity propagation C: negative one minus Pearson’s correlation
coefficient; E: negative Euclidean distance
yes [32]
MBHC: multinomial BHC - yes [19,23]
A: average-linkage hierarchical
clustering
C: one minus Pearson’s correlation coefficient;
E: Euclidean distance
no [10]
C: complete-linkage hierarchical
clustering
C: one minus Pearson’s correlation coefficient;
E: Euclidean distance
no [11,12,33]
K: k-means C: one minus Pearson’s correlation coefficient;
E: square Euclidean distance
no [13]
doi:10.1371/journal.pone.0075748.t001
Table 2. Dataset detail.
Dataset Name # Total Samples # Classes Classes # Total Probes
# Remaining
Probes
Blood1 [34] 72 2 24 ALL, 48 MLL 12,582 1,081
Blood2 [35] 77 2 58 DLBCL, 19 FL 7,129 798
Bone Marrow [36] 72 2 47 ALL, 25 AML 7,129 1,868
Brain1 [37] 28 2 14 CG, 14 NG 12,625 1,070
Brain2 [38] 42 5 10 MD, 10 Mglio, 10 Rhab, 4 Ncer, 8 PNET 7,129 1,379
Colon [39] 37 2 8 serrated CRC, 29 conventional CRC 22,883 2,202
Lung 16 3 7 NL, 5 LCNEC, 4 SCLC 42,545 2,995
Multi-tissue1 [40] 190 14 11 BR, 10 PR, 11 LU, 11 CRC, 22 LY, 10 ML, 11 BL,
10 UT, 30 LE, 11 RE, 11 PA, 11 OV, 11 ME, 20 CNS
16,063 1,363
Multi-tissue2 [41] 174 10 26 PR, 8 BL, 26 BR, 23 CRC, 12 GA, 11 KI, 7 LI, 27
OV, 6 PA, 28 LU
12,533 1,571
Prostate1 [42] 102 2 50 NP, 52 PR 12,600 339
Prostate2 [43] 19 3 6 benign, 7 primary, 6 metastatic 54,675 1,348
ALL: acute lymphoblastic leukemia; AML: acute myelogenous leukemia; BL: bladder/ureter cancer; BR: breast cancer; CG: classic glioblastoma; CNS: central nervous
system; CRC: colorectal cancer; DLBCL: diffuse large B-cell lymphoma; FL: follicular lymphoma; GA: esophageal cancer; KI: kidney cancer; LCNEC: large cell
neuroendocrine carcinoma; LE: leukemia; LI: liver cancer; LU: lung cancer; LY: lymphoma; MD: medulloblastoma; ME: pleural mesothelioma; Mglio: malignant glioma; ML:
melanoma; MLL: lymphoblastic leukemia with myeloid/lymphoid or mixed-lineage leukemia (MLL) translocations; Ncer: normal cerebella; NG: nonclassic glioblastoma;
NL: normal lung tissue; NP: normal prostate tissue; OV: ovarian cancer; PA: pancreatic cancer; PNET: primitive neuroectodermal tumour; PR: prostate cancer; RE: renal cell
carcinoma; Rhab: atypical teratoid/rhabdoid tumour; SCLC: small cell lung carcinoma; UT: uterine cancer;
doi:10.1371/journal.pone.0075748.t002
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Figure 2. Clustering Results of Synthetic Dataset1. Clusters are represented by different colors or types of marker. A) 7 actual clusters. B)
Clustering result produced by GBHC-TREE has 7 clusters. C) Clustering result produced by GBHC-NODE has 7 clusters. D) Clustering result produced
by AE has 7 clusters.
doi:10.1371/journal.pone.0075748.g002
Figure 3. Clustering Results of Synthetic Dataset2. Clusters are represented by different colors or types of marker. A) 7 actual clusters. B)
clustering result produced by GBHC-TREE has 14 clusters. C) clustering result produced by GBHC-NODE has 37 clusters. D) clustering result produced
by KE has 4 clusters.
doi:10.1371/journal.pone.0075748.g003
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value v0:05; Section S6, Table S5 in Material S1). In terms of
accuracy in inferring the number of sample classes (Section S6,
Tables S6,S7 in Material S1), the first three algorithms on average
are GBHC-TREE, KE, and GBHC-NODE, but there are no
significant differences between them (p-value v0:05; Section S6,
Table S8 in Material S1).
For gene clustering, Table 5 shows that GBHC-NODE and
GBHC-TREE give the best BHI in 2 datasets (Brain1, Multi-
tissue2) and 1 dataset (Lung), respectively, while the maximum and
the mean of number of datasets that each algorithm gives the best
BHI are 3 and 1.17, respectively. On average, the first three
algorithms with the highest mean BHI are APE, GBHC-NODE,
and GBHC-TREE. Again, there are no significant differences
between them (p-valuev0:05; Section S7, Table S10 in Material
S1). The number of gene clusters inferred by the algorithms can
also be found on Section S7, Table S11 in Material S1.
In terms of execution time (Section S6, Table S9 and Section
S7, Table S12 in Material S1), GBHC-TREE and GBHC-NODE
are slower than non-BHC methods because of their high
computational load, contributed from the statistical model and
the hyperparameters optimization. As expected, GBHC-TREE
and GBHC-NODE will not always perform better than other
clustering algorithms in every dataset since underlying structure of
natural data is more complicated and in general do not comply to
the Assumptions A1–A3. Nonetheless, we can see from the results
that GBHC-TREE and GBHC-NODE are the only algorithms
that on average produces higher quality results in both sample and
gene clustering. Moreover, they are more likely to infer the
number of sample classes which are close to the actual one.
Comparison between BHC algorithms. In comparison to
MBHC, for sample clustering, GBHC-NODE and GBHC-
TREE produce higher ARI than MBHC, but GBHC-NODE
Figure 4. Clustering Results of Synthetic Dataset3. Clusters are represented by different colors or types of marker. A) 7 actual clusters. B)
Clustering result produced by GBHC-TREE has 22 clusters. C) Clustering result produced by GBHC-NODE has 12 clusters. D) Clustering result produced
by KE has 5 clusters.
doi:10.1371/journal.pone.0075748.g004
Table 3. Adjusted Rand Index from Synthetic Data Clustering Experiment.
Dataset APC APE GBHC-TREE GBHC-NODE MBHC AC AE CC CE KC KE
Synthetic
Dataset1
0.317 0.230 1.000 1.000 0.648 0.938 0.996 0.932 0.954 0.547 0.851
Synthetic
Dataset2
0.106 0.095 0.467 0.270 0.143 0.324 20.000 0.132 0.088 0.312 0.413
Synthetic
Dataset3
0.295 n/a 0.897 0.921 0.643 0.479 0.002 0.710 0.506 0.495 0.750
mean 0.239 0.163 0.788 0.730 0.478 0.581 0.333 0.592 0.516 0.451 0.671
n/a: not applicable since the algorithm does not converge. Bold number(s) in each dataset highlight(s) the maximum ARI value. Bold underlined numbers highlight the
first three highest average ARIs.
doi:10.1371/journal.pone.0075748.t003
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gives significantly higher result (Section S6, Table S5 in
Material S1). Moreover, they give significantly lower differ-
ence between inferred and actual number of sample classes
than MBHC (Section S6, Table S8 in Material S1). Regarding
the execution time, GBHC-NODE runs around 4 times faster
than MBHC, and around 11 times faster than GBHC-TREE
in sample clustering (Section S6, Table S9 in Material S1).
For gene clustering, GBHC-NODE runs around 1.2 times
faster than MBHC and around 6.3 times faster than GBHC-
TREE (Section S7, Table S12 in Material S1). We note that
GBHC-TREE and MBHC run slower than GBHC-NODE
because their hyperparameter optimizations are more compu-
tationally intensive, as they require the clustering result of the
whole data to evaluate the objective function. Thus, GBHC-
TREE and GBHC-NODE gain improved clustering quality,
and GBHC-NODE also gains a speed-up.
Conclusions
In this paper, we presented a model-based clustering algorithm
which employs a Gaussian mixture model to model the gene
expression profiles in a Bayesian framework. The proposed
algorithm, termed as the Gaussian BHC or GBHC, uses a
Gaussian mixture model together with a normal-gamma prior for
the unknown mean and precision parameters of the mixture
components in order to capture the intrinsic structure of the data.
We proposed two variations of the GBHC algorithm: GBHC-
TREE and GBHC-NODE, according to two different hyperpara-
Table 4. Adjusted Rand index from Sample Clustering Experiment.
Dataset APC APE GBHC-TREE GBHC-NODE MBHC AC AE CC CE KC KE
Blood1 [34] 0.246 0.147 0.551 0.474 0.382 0.175 0.206 0.533 0.175 0.576 0.544
Blood2 [35] 0.052 0.049 0.066 0.100 0.053 0.013 0.034 0.038 20.017 0.014 0.006
Bone Marrow [36] 0.044 0.036 0.095 20.013 0.025 0.031 20.037 0.040 0.051 0.050 0.081
Brain1 [37] 20.018 0.159 0.129 0.194 0.200 20.017 20.013 20.036 0.107 20.026 0.103
Brain2 [38] 0.433 0.497 0.460 0.525 0.419 0.575 0.483 0.421 0.400 0.480 0.401
Colon [39] 0.017 0.068 0.000 0.000 0.021 20.093 0.110 0.039 20.044 0.078 0.078
Lung 0.660 0.660 0.660 0.660 0.540 0.642 0.642 0.844 0.844 0.657 0.728
Multi-tissue1 [40] 0.466 0.190 0.310 0.394 0.476 0.179 0.007 0.406 0.110 0.179 0.139
Multi-tissue2 [41] 0.216 0.215 0.243 0.253 0.215 0.087 0.005 0.215 0.162 0.142 0.216
Prostate1 [42] 0.067 0.047 0.036 0.136 0.097 0.026 0.026 0.013 0.030 0.014 0.024
Prostate2 [43] 1.000 1.000 1.000 1.000 0.836 1.000 0.788 0.883 0.836 1.000 1.000
mean 0.289 0.279 0.323 0.338 0.297 0.238 0.204 0.309 0.241 0.287 0.302
SEM 0.097 0.094 0.095 0.093 0.078 0.104 0.089 0.101 0.096 0.102 0.099
SEM: standard error of the mean. Bold number(s) in each dataset highlight(s) the maximum ARI value. Bold underlined numbers highlight the first three highest average
ARIs.
doi:10.1371/journal.pone.0075748.t004
Table 5. Biological homogeneity index from Gene Clustering Experiment.
Dataset APC APE GBHC-TREE GBHC-NODE MBHC AC AE CC CE KC KE
Blood1 [34] 0.269 0.276 0.298 0.278 0.252 0.251 0.373 0.250 0.256 0.246 0.249
Blood2 [35] 0.276 0.289 0.283 0.278 0.268 0.338 0.219 0.262 0.219 0.267 0.271
Bone Marrow [36] 0.273 0.296 0.266 0.288 0.310 0.251 0.298 0.269 0.299 0.269 0.271
Brain1 [37] 0.291 0.322 0.301 0.322 0.303 0.231 0.287 0.281 0.282 0.283 0.281
Brain2 [38] 0.271 0.276 0.298 0.258 0.267 0.245 0.356 0.258 0.255 0.262 0.266
Colon [39] 0.254 0.276 0.292 0.303 0.307 0.234 0.260 0.241 0.270 0.243 0.253
Lung 0.244 0.247 0.269 0.261 0.243 0.250 0.259 0.269 0.261 0.250 0.247
Multi-tissue1 [40] 0.311 0.333 0.259 0.284 0.272 0.244 0.290 0.268 0.274 0.272 0.280
Multi-tissue2 [41] 0.293 0.336 0.294 0.342 0.302 0.259 0.257 0.250 0.246 0.257 0.256
Prostate1 [42] 0.378 0.359 0.367 0.331 0.371 0.283 0.339 0.297 0.333 0.300 0.316
Prostate2 [43] 0.257 0.276 0.263 0.276 0.289 0.265 0.088 0.254 0.267 0.264 0.262
mean 0.283 0.299 0.290 0.293 0.289 0.259 0.275 0.264 0.269 0.265 0.268
SEM 0.011 0.010 0.009 0.008 0.011 0.009 0.023 0.005 0.009 0.005 0.006
SEM: standard error of the mean. Bold number(s) in each dataset highlight(s) the maximum BHI value. Bold underlined number highlight the first three highest average
BHIs.
doi:10.1371/journal.pone.0075748.t005
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meter optimization schemes. An extensive comparison between
these variations and other well-known clustering algorithms was
conducted based on 3 synthetic datasets and 11 cancer datasets.
The experimental results on synthetic datasets showed that
GBHC-TREE and GBHC-NODE, generally outperformed the
other clustering algorithms if the data were normalized and could
be well-represented by a mixture of multivariate Gaussian
distributions where each variate was independent from the others.
Although, the data were highly deviated from a mixture of
multivariate Gaussian distributions or had moderate degree of
correlation between variables, GBHC-NODE and GBHC-TREE
still improved the clustering results. For gene expression clustering,
both GBHC-TREE and GBHC-NODE gave strong performances
on the whole. They consistently produced higher quality results in
both sample and gene clustering and were more likely than the
other clustering algorithms in inferring the number of actual
sample classes. Compared to MBHC which is a previous extension
of BHC for microarray data, the GBHC algorithms also had better
clustering performances. Further, our formulation of the log-
likelihood allowed us to use a conjugate gradient algorithm to
efficiently find optimal hyperparameters leading to the GBHC-
NODE variant being on average over 10 times faster than the
GBHC-TREE variant of our algorithm without compromising
clustering performance.
Availability
The MATLAB implementation of GBHC-TREE and GBHC-
NODE are available at https://sites.google.com/site/
gaussianbhc/
Supporting Information
Material S1 Bayesian hierarchical clustering for Study-
ing Cancer Gene Expression Data with Unknown
Statistics.
(PDF)
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